Carcinogenesis modeling: from molecular biology to epidemiology

scientific article

Carcinogenesis modeling: from molecular biology to epidemiology is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1146/ANNUREV.PU.07.050186.001055
P698PubMed publication ID3521642

P2093author name stringMoolgavkar SH
P921main subjectmolecular biologyQ7202
epidemiologyQ133805
carcinogenesisQ1637543
P304page(s)151-169
P577publication date1986-01-01
P1433published inAnnual Review of Public HealthQ15751557
P1476titleCarcinogenesis modeling: from molecular biology to epidemiology
P478volume7

Reverse relations

cites work (P2860)
Q573836201988 Herbert E. Stokinger Lecture: Quantitative Risk Assessment and Occupational Carcinogens
Q37021482A bibliography and comments on the use of statistical models in epidemiology in the 1980s
Q34841737A model-free approach to low-dose extrapolation
Q53512247A two-stage carcinogenesis model for risk assessment.
Q33864770Ah receptor ligands and tumor promotion: survival of neoplastic cells
Q34660343Assessing the effects of metabolism of environmental agents on cancer tumor development by a two-stage model of carcinogenesis
Q42406644Biological bases for cancer dose-response extrapolation procedures
Q52547638Carcinogenic risk assessment with time-dependent exposure patterns.
Q71879837Comparison of contact site cancer potency across dose routes: case study with epichlorohydrin
Q40847990Concerning ionizing radiation-induced cancer from internally deposited radionuclides
Q35033447Consistent associations between hepatic lesions in English sole (Parophrys vetulus) and polycyclic aromatic hydrocarbons in bottom sediment
Q37526969Derivation of inhalation toxicity reference values for propylene oxide using mode of action analysis: example of a threshold carcinogen
Q52288225Dose-response relationship for rat liver DNA damage caused by 1,2-dimethylhydrazine.
Q35031138Dose-response relationship in multistage carcinogenesis: promoters
Q70215319Druckery slope controlled by mitotic rate of enzymatically-altered foci
Q28388932Evaluation of health risks for contaminated aquifers
Q73805372Game-theory models of interactions between tumour cells
Q34660257High- to low-dose extrapolation: critical determinants involved in the dose response of carcinogenic substances
Q36448889Identifying soil cleanup criteria for dioxins in urban residential soils: how have 20 years of research and risk assessment experience affected the analysis?
Q41288928Incorporation of biological information in cancer risk assessment: example--vinyl chloride
Q35571581Invited Reviews: Carcinogenic and Systemic Health Effects Associated with Arsenic Exposure—A Critical Review
Q37031674Large population solution of the stochastic Luria-Delbruck evolution model
Q23911646Lung cancer in chrysotile asbestos workers: analyses based on the two-stage clonal expansion model
Q34308465Mode of action and tissue dosimetry in current and future risk assessments
Q23916894Modeling epidemiologic studies of occupational cohorts for the quantitative assessment of carcinogenic hazards
Q34537475Modeling lung cancer risk in case-control studies using a new dose metric of smoking
Q35032734Multistage models for carcinogenesis
Q37350827On the probability of random genetic mutations for various types of tumor growth.
Q34276826Population genetics meets cancer genomics
Q50156197Predicting rodent carcinogenicity of Ames test false positives by in vivo biochemical parameters
Q33472998Predicting the carcinogenicity of chemicals in humans from rodent bioassay data
Q41137547Quantitation of multistage carcinogenesis in rat liver
Q37969569Quantitative factors in chemical carcinogenesis: variation in carcinogenic potency
Q33586636Recent developments in the multistage modeling of cohort data for carcinogenic risk assessment
Q44033528Risk assessment of 2,3,7,8-TCDD using a biologically based cancer model: a reevaluation of the Kociba et al. bioassay using 1978 and 1990 histopathology criteria
Q38568559Scaling solution in the large population limit of the general asymmetric stochastic Luria-Delbrück evolution process
Q34410886The mutation rate and cancer
Q73552224The population genetics of multistage carcinogenesis
Q40438450The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: Transforming growth factor α expression as a marker for the stage of progression
Q57383602Tissue dosimetry, physiologically-based pharmacokinetic modeling, and cancer risk assessment
Q37798577Translational research in oncology: key bottlenecks and new paradigms
Q37940155Two-event model for carcinogenesis: biological, mathematical, and statistical considerations

Search more.